Dogwood Therapeutics, Inc. (DWTX) — Net Asset Momentum
Dogwood Therapeutics, Inc. (DWTX) recorded a net asset momentum of 1588.5% as of December 2024, with net assets of $64.28 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see DWTX market cap overview.
YoY Momentum
Current Net Assets
Years of Data
Country
Dogwood Therapeutics, Inc. Net Asset Momentum (2018–2024)
This chart tracks Dogwood Therapeutics, Inc.'s year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +1588.5%, with net assets of $64.28 Million USD as of December 2024. See net asset quality index of Dogwood Therapeutics, Inc. to measure how much of total assets are equity-financed.
Annual Net Asset History for Dogwood Therapeutics, Inc. (2018–2024)
The table below shows the complete annual net asset history for Dogwood Therapeutics, Inc. from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Dogwood Therapeutics, Inc. to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $64.28 Million | $94.31 Million | $30.03 Million | ▲ +1588.5% |
| 2023 | $3.81 Million | $4.17 Million | $358.55K | ▼ -48.0% |
| 2022 | $7.33 Million | $8.37 Million | $1.04 Million | ▼ -49.5% |
| 2021 | $14.50 Million | $15.78 Million | $1.28 Million | ▼ -51.6% |
| 2020 | $29.94 Million | $31.47 Million | $1.53 Million | ▲ +705.8% |
| 2019 | $-4.94 Million | $315.90K | $5.26 Million | ▼ -292.1% |
| 2018 | $-1.26 Million | $65.94K | $1.33 Million | — |